Feed A
A

Agilent Technologies

A · NYSE

$156.29 +1.69% (+$2.60)
1M -1.11%
Market Cap $41.5B
P/E Ratio 28.80x
Div. Yield 0.52%
ROE 20.47%

Bulios Fair Price

$135.09

13.6% downside

Current Price

$156.29

Undervalued Fair Value Overvalued

According to Bulios Fair Price, A is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
6/9
Valuation
28 /100
Expensive
PEG 29.30x
P/S 5.63x
P/B 5.63x
Growth
36 /100
Stable
Rev. growth 0.48%
FCF growth 4.11%
Book val. growth 8.31%
Profitability
93 /100
Strong
Net margin 19.53%
Op. margin 22.23%
FCF margin 20.56%
Quality
74 /100
Excellent
ROE 20.47%
ROA 10.31%
Asset turnover 0.53x
Debt
88 /100
Low
Current ratio 2.05x
Int. coverage 26.90x
Net debt/EBITDA 1.13x
Stability
89 /100
Stable
Rev. volatility 5.77%
EPS volatility 2.75%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about A
Online

About the company

Agilent Technologies, Inc. is an American technology company specializing in the development and manufacturing of analytical and diagnostic technologies. The company provides a wide range of products and services used in scientific research, industrial analysis, pharmaceutical sector, and diagnostic laboratories. Agilent manufactures laboratory instruments, measurement and analytical instruments, software, and reagents that enable customers to perform precise analyses and testing in various industries. The company is known for the quality of its products, technological leadership, and innovations, which make it a leader in the analytical industry. Agilent Technologies collaborates with research institutions, industrial companies, and healthcare facilities worldwide. Agilent Technologies, Inc. (A) shares are an interesting choice for investors who follow the technology industry and seek investment opportunities in an innovative and established company with a global reach.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Padraig McDonnell

Employees

18,100

Headquarters

Santa Clara

Upcoming events

23 NOV

Earnings

Upcoming earnings report

66d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.